News

Trontinemab Alzheimer’s treatment

Trontinemab Alzheimer’s Treatment: A Breakthrough Drug with Fast, Safe Results

The new Trontinemab Alzheimer’s treatment represents a major advance in dementia therapy. In recent clinical trials, this breakthrough drug cleared amyloid plaques faster than any existing option, with fewer side effects. Alzheimer’s experts now see Trontinemab as a top candidate to change the future of brain health. How Trontinemab Alzheimer’s Treatment Works Trontinemab is an […]

Trontinemab Alzheimer’s Treatment: A Breakthrough Drug with Fast, Safe Results Read More »

Neuroassay Biomarkers for Alzheimer’s and Parkinson’s Uncovered

Neuroassay Biomarkers: New Study Reveals Breakthroughs A global proteomics study has revealed crucial neuroassay biomarkers for Alzheimer’s and Parkinson’s. Researchers analyzed over 250 million protein measurements from 35,000 biosamples to uncover disease-specific signatures that may revolutionize early diagnosis. How Neuroassays Detect Biomarkers in Alzheimer’s and Parkinson’s Neuroassays are powerful diagnostic tools that identify protein biomarkers

Neuroassay Biomarkers for Alzheimer’s and Parkinson’s Uncovered Read More »

AAV‑DB‑3 neuronal gene therapy

AAV-DB-3 Neuronal Gene Therapy: Breakthrough in Neurogenetics

AAV-DB-3 Neuronal Gene Therapy AAV-DB-3 neuronal gene therapy is a revolutionary approach in the field of neurogenetics. It involves a specially engineered adeno-associated virus (AAV) designed to deliver therapeutic genes directly into neurons. This method stands out due to its high selectivity and ability to minimize off-target effects. How AAV-DB-3 Improves Gene Delivery The key

AAV-DB-3 Neuronal Gene Therapy: Breakthrough in Neurogenetics Read More »

Breakthrough Neuroassay Findings Reveal New Biomarkers for Early Detection of Alzheimer’s

New Neuroassay Findings for Early Alzheimer’s Detection New Neuroassay Findings for Early Alzheimer’s Detection Recent neuroassay findings from researchers at the University of California, San Diego, have uncovered new biomarkers for early-stage Alzheimer’s diagnosis. This breakthrough may significantly improve early detection and treatment strategies. What Do These Neuroassay Findings Show? Using advanced multiplex neuroassay technology,

Breakthrough Neuroassay Findings Reveal New Biomarkers for Early Detection of Alzheimer’s Read More »

Laser Helmet for Parkinson’s Disease | NeuroThera Study

Laser Helmet for Parkinson’s Disease | NeuroThera Study Laser Helmet for Parkinson’s Disease: NeuroThera’s Non-Invasive Therapy NeuroThera is developing a laser helmet for Parkinson’s disease that could transform how we treat neurological conditions. This non-invasive method uses infrared light to stimulate brain activity without the need for medication or surgery. Laser Helmet Study Shows Promising

Laser Helmet for Parkinson’s Disease | NeuroThera Study Read More »

Latest Advances in Neuroassay Technology: Biomarkers, DBS, and AI Diagnostics

Latest Advances in Neuroassay Technology Neuroassay technologies are rapidly evolving, offering faster, non-invasive, and more accurate diagnostics for neurological disorders. This article highlights three major breakthroughs in the field from 2025. 1. sTREM2 Assay by Fujirebio Fujirebio has launched the Lumipulse G sTREM2 assay—a fully automated chemiluminescent test that measures soluble TREM2 in cerebrospinal fluid

Latest Advances in Neuroassay Technology: Biomarkers, DBS, and AI Diagnostics Read More »

NeuroTherapia Gains EMA Approval for Phase 2 Alzheimer’s Trial

NeuroTherapia Alzheimer’s Trial Begins After EMA Approval NeuroTherapia is a biotech company that develops treatments for brain inflammation. Recently, it received approval from the European Medicines Agency (EMA) to start a Phase 2 clinical trial of NTRX‑07, its lead drug candidate. This trial will focus on Alzheimer’s disease. It follows earlier Phase 1 studies that

NeuroTherapia Gains EMA Approval for Phase 2 Alzheimer’s Trial Read More »

Neurothera Brain Injury Recovery: New Light-Based Breakthrough

Neurothera Offers Faster, Non-Invasive Brain Healing A new breakthrough in Neurothera brain injury recovery is offering faster results for patients. Scientists at a leading neurological center have developed a device that uses near-infrared light to activate natural brain repair. The therapy is painless, non-invasive, and drug-free. This approach, known as low-level light therapy (LLLT), boosts

Neurothera Brain Injury Recovery: New Light-Based Breakthrough Read More »

NeuroThera Launches New Brain Stimulation Technology for Stroke Recovery

NeuroThera Launches New Brain Stimulation Technology for Stroke Recovery A New Hope for Stroke Patients NeuroThera has introduced a new non-invasive brain stimulation device designed to enhance stroke recovery. This cutting-edge technology offers fresh hope to patients and healthcare professionals around the world. How the Device Works The device uses low-level laser therapy (LLLT) to

NeuroThera Launches New Brain Stimulation Technology for Stroke Recovery Read More »

NeuroAssaydentifies New Blood Biomarkers for Early Detection of Brain Disorders

NeuroAssaydentifies New Blood Biomarkers for Early Detection of Brain Disorders Breakthrough Panel Targets Early-Stage Neurological Conditions In a major scientific advance, NeuroAssays has introduced a novel panel of blood-based biomarkers that significantly improves early diagnosis of neurological diseases. This innovation aims to detect subtle changes in brain function before structural damage occurs, offering new hope

NeuroAssaydentifies New Blood Biomarkers for Early Detection of Brain Disorders Read More »